<- Go Home
Carmat SA
Carmat SA designs and develops total artificial heart for patients with advanced heart failure in France and internationally. The company offers Aeson, an active implantable medical device intended to replace the ventricles of the native heart in patients suffering from advanced heart failure. The company was incorporated in 2008 and is headquartered in Vélizy-Villacoublay, France.
Market Cap
EUR 6.1M
Volume
111.4K
Cash and Equivalents
EUR 4.7M
EBITDA
-EUR 47.2M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
-EUR 36.3M
Profit Margin
494.88%
52 Week High
EUR 0.95
52 Week Low
EUR 0.09
Dividend
N/A
Price / Book Value
-0.12
Price / Earnings
-0.09
Price / Tangible Book Value
-0.12
Enterprise Value
EUR 59.2M
Enterprise Value / EBITDA
-1.25
Operating Income
-EUR 49.2M
Return on Equity
167.84%
Return on Assets
-64.45
Cash and Short Term Investments
EUR 4.7M
Debt
EUR 57.8M
Equity
-EUR 34.3M
Revenue
EUR 7.3M
Unlevered FCF
-EUR 27.7M
Sector
Professional Services
Category
N/A